Piérard-Franchimont C
United Laboratories
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Piérard-Franchimont C.
Journal of Cosmetic Dermatology | 2006
Pascale Quatresooz; Piérard-Franchimont C; Ulysse Gaspard; Gérald Pierard
A gender perspective is indispensable for a full understanding of aging. Menopause is a turning point in womens lives. In addition to the effects of chronological aging, sunlight exposure, and other environmental and endogenous stimuli, the climacteric appears to exert some dramatic consequences on skin biology and aspect. The epidermis may become xerotic and exhibit altered functions. The dermis thins out and its elasticity decreases in concert with the decline in bone mass. The skin microcirculation is impaired. These aspects are some of the better worked‐out changes of the climacteric, which in turn seem to be stabilized or in part reversible with hormone replacement therapy (HRT). The HRT effect on menopause consequences on hair growth and sebum production is less impressive. This review summarizes some important impacts of the climacteric on skin, and highlights the benefits of HRT that may influence cosmetic dermatology.
Journal of Cosmetic Dermatology | 2005
Piérard-Franchimont C; J F Hermanns; Trinh Hermanns-Lê; Gérald Pierard
Introduction Striae distensae in White people are commonly described as being reddish at first and turning white in time. This dual perception has been challenged. Indeed, the color difference between striae distensae and their surrounding skin varies on a wide range in part depending upon typology.
Expert Opinion on Emerging Drugs | 2007
Gérald Pierard; Jorge E. Arrese; Pascale Quatresooz; Piérard-Franchimont C
Onychomycosis is a frequent disorder that represents the most prevalent fungal infection, particularly among older individuals. Diverse fungi of the dermatophyte, non-dermatophyte mold and yeast families have been reported to be responsible for onychomycosis. The output from the pharmaceutical industry of new antifungals to treat onychomycosis has been limited over the last decade. Present treatment options include both oral and topical drugs, with oral therapies giving better outcomes. However, neither of these treatment options provides high cure rates that are durable. At present, azoles and allylamines are keeping the pivotal roles. New derivatives with a favorable risk-benefit ratio and new formulations of older azoles seem to be promising. Thus, ongoing drug development activities have focused on novel delivery technologies to facilitate incorporation of existing antifungal drugs inside the nail plate and the discovery of new active antifungals.
Journal of Cosmetic Dermatology | 2002
Philippe Paquet; I Fumal; Piérard-Franchimont C; Gérald Pierard
Background Unwanted male‐pattern pilosity is a heavy psychological burden and can cause distress for male‐to‐female transsexuals. Orchidectomy and oestrogen supplementation combined with antiandrogens fail to make hair disappear.
Revue médicale de Liège | 2005
Frédérique Henry; Piérard-Franchimont C; Piérard Ge
Revue médicale de Liège | 2005
Emmanuelle Uhoda; Debatisse B; Philippe Paquet; Piérard-Franchimont C; Piérard Ge
Revue médicale de Liège | 2000
Piérard Ge; Jorge E. Arrese; Piérard-Franchimont C
Revue médicale de Liège | 2012
Piérard Ge; Piérard-Franchimont C; Hermanns-Lê T; Philippe Delvenne
Revue médicale de Liège | 2011
Piérard-Franchimont C; Jean-François Hermanns; Piérard Ge
Revue médicale de Liège | 2002
Frédérique Henry; Jorge E. Arrese; Nadine Claessens; Piérard-Franchimont C; Piérard Ge